• VIB spin-off Flamingo Therapeutics merges with Dynacure to create leading RNA therapeutics company in oncology

    Thursday March 2nd 2023

  • Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

    Tuesday February 7th 2023

  • Weber joins Vivactis Group to reinforce its Market Access capabilities

    Thursday February 2nd 2023

  • InnoSer expands its preclinical neuroscience expertise with the acquisition of Sylics

    Friday January 13th 2023

  • Beiersdorf acquires S-Biomedic and strengthens expertise in the field of acne treatment

    Friday December 16th 2022

  • Analis takes over Vos Instrumenten

    Tuesday December 13th 2022

  • The QbD Group acquires regulatory affairs and pharmacovigilance company EUDRAC Ltd to expand its services for pharmaceutical customers

    Tuesday November 8th 2022

  • Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation of Medsenic valued at EUR 40 million

    Tuesday October 25th 2022

  • Your news here?

  • Bone Therapeutics to regain worldwide rights to ALLOB

    Friday October 7th 2022

  • Pauwels Consulting takes over Science@Work

    Friday September 23rd 2022

  • Cellistic and Celyad Oncology announce GMP cell therapy manufacturing operations transaction

    Tuesday September 20th 2022

Strategic Partners